Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with atrial fibrillation
Crossref DOI link: https://doi.org/10.1007/s11239-017-1495-z
Published Online: 2017-03-18
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Steppich, B.
Dobler, F.
Brendel, L. C.
Hessling, G.
Braun, S. L.
Steinsiek, A. L.
Deisenhofer, I.
Hyseni, A.
Roest, M.
Ott, I.
License valid from 2017-03-18